Biotechnology and its effects on the pharmaceutical industry

Abstract

Biotechnology is widely regarded as a central pillar of agricultural production, industrial development, and modern medicine. It is expected to provide a fundamental scientific basis for addressing some of the most pressing challenges facing humanity in the contemporary era. Although its origins can be traced back several centuries, biotechnology has acquired particular significance in the modern period, which may rightly be described as a distinctly biological age. At its core, biotechnology is primarily concerned with two fundamental domains: food production and medical treatment. Its medical applications began in the mid-twentieth century with the production of antibiotics and pharmaceutical drugs, before expanding to include genetic engineering, recombinant DNA technology, the manipulation and transfer of genetic codes in animals, and gene therapy. Biotechnology is one of the most promising scientific fields for the development of more effective treatments and vaccines against complex and life-threatening diseases, including cancer and immunodeficiency disorders. Nevertheless, despite its considerable benefits for human health and well-being, biotechnology also raises significant legal, ethical, and socio-economic concerns. These include the potential imbalance between inherited biological characteristics and acquired technological interventions, as well as the unequal distribution of benefits between developed and developing countries.